DARPA is the one creating vaccines for Coronavirus by cloning antibodies

A Pentagon agency is working to produce an antibody treatment to combat the novel coronavirus until a vaccine is ready.

The Defense Advanced Research Projects Agency (DARPA), a research and funding branch of the Defense Department known for its out-of-the-box innovations, aims to “make pivotal investments in breakthrough technologies for national security.” Its inventions include the internet, Siri, GPS, videoconferencing and even self-driving cars. 

Now, DARPA is racing against time as experts warn of a likely second wave of the coronavirus this fall.

Dr. Amy Jenkins leads DARPA’s Pandemic Prevention Platform (P3). The program, which launched in 2018, works with outside researchers to develop a quick response to emerging infectious diseases with a goal of delivering medical countermeasures in 60 days. P3 is currently working with two universities, Duke and Vanderbilt, and two pharmaceutical companies, AbCellera and AstraZeneca, on a COVID-19 response.

DARPA’s real objective is genetically modifying human by the vaccines with CRISPR technology so that DARPA can use us just like their robots.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s